Clonexpress Revenue

Biotechnology Research • 504 E Diamond Ave, Suite G, United States • 1-10 Employees

Clonexpress revenue & valuation

Annual revenue	$6,599,063
Revenue per employee	$3,300,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$21,200,000
Total funding	No funding

Key Contact at Clonexpress

Thiru V Gopal

Regional Vice President

Company overview

Headquarters	504 E Diamond Ave, Suite G, Gaithersburg, Maryland 20877, US
Phone number	+13018690840
Website	clonexpress.com
NAICS	541714
SIC	873
Keywords	Custom Development Of Cell Lines, Human Cns And Other Primary Cells
Founded	1992
Employees	1-10
Socials

About Clonexpress

Clonexpress has developed a novel technology platform to generate patient-specific differentiated cell types by epigenetic induction. Clonexpress has developed patient specific pancreatic beta cells, hepatocytes, and dopaminergic neuron cells from adult human fibroblasts and peripheral blood mononuclear cells (three issued patents- US9,029,141B2,US9,394,525 and US10,100,280B2). Clonexpress has developed human pancreatic beta islets cell line (glucose responsive insulin release similar to primary beta cells) and hepatocyte (metabolism qualified ) cell lines. These cell lines are very close to normal cells and are available for licensing or purchase for drug discovery and toxicology applications. Clonexpress has recently developed a human microglial cell line available for licensing or purchase. Custom development of tumor cell lines from tumor samples provided by the client -successfully developed multiple myeloma and other cell types from tumor samples provided by clients Custom cell line development of cell lines using primary cells provided by client (both human and non-human) for research use. Clonexpres has discovered a common growth control mechanism in different types of cancers, and such growth control mechanism is not present in different normal cells (fibroblasts and mesenchymal cells) capable of continuous growth in culture. This is a totally new paradigm to develop new class of drugs with minimal or no side effects to cure cancer and metastasis. Clonexpress has developed a very sensitive assay to identify the target. Clonexpress is actively seeking funding /partnership opportunities to use this technology to find a cure for different types of cancer. Clonexpress also provides human central nervous system (CNS) primary cells - neuronal progenitor cells, dopaminnergic neuron cells, astrocytes, and microglial cells, diffetrent endothelial cells, human fibroblasts, bone marrow stromal cells, liver mesenchymal cells to for research.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Vice President

Funding Data

Clonexpress has never raised funding before.

Frequently asked questions

Clonexpress is located in 504 E Diamond Ave, Suite G, US.

You can reach Clonexpress at +13018690840.

Clonexpress generates an estimated annual revenue of $6,599,063. This revenue figure reflects the company's market position and business performance in its industry.

Clonexpress has an estimated valuation of $21,200,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Clonexpress was founded in 1992, making it 34 years old. The company has established itself as a significant player in its industry over this time.

Clonexpress has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Clonexpress

Thiru V Gopal

Regional Vice President

4.8

40,000 users